Virtus ETF Advisers’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $38.5K | Sell |
|
|||||
|
2023
Q2 | $85.1K | Buy |
|
|||||
|
2023
Q1 | $92.7K | Sell |
|
|||||
|
2022
Q4 | $127K | Sell |
|
|||||
|
2022
Q3 | $248K | Buy |
|
|||||
|
2022
Q2 | $132K | Buy |
|
|||||
|
2022
Q1 | $137K | Sell |
|
|||||
|
2021
Q4 | $170K | Buy |
|
|||||
|
2021
Q3 | $72K | Sell |
|
|||||
|
2021
Q2 | $258K | Sell |
|
|||||
|
2021
Q1 | $249K | Buy |
|
|||||
|
2020
Q4 | $291K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $563K | Buy |
|
|||||
|
2017
Q4 | $358K | Buy |
|
|||||
|
2017
Q3 | $518K | Buy |
|
|||||
|
2017
Q2 | $331K | Sell |
|
|||||
|
2017
Q1 | $351K | Buy |
|
|||||
|
2016
Q4 | $279K | Buy |
|
|||||
|
2016
Q3 | $100K | Hold |
|
|||||
|
2016
Q2 | $235K | Buy |
|
|||||
|
2016
Q1 | $175K | Buy |
|